市場調查報告書
商品編碼
1510646
2030 年亞太地區醫療保健 CRM 市場預測 - 區域分析 - 按部署模式、產品類型、應用程式和最終用戶Asia Pacific Healthcare CRM Market Forecast to 2030 - Regional Analysis - by Deployment Mode, Product Type, Application, and End User |
2022年亞太地區醫療保健CRM市場價值為11.6617億美元,預計到2030年將達到27.455億美元;預計2022年至2030年複合年成長率為11.3%。
物聯網和人工智慧知識的增加推動亞太地區醫療保健 CRM 市場的發展
對數據驅動的洞察、分析和人口健康管理的需求正在極大地促進醫療保健產業的發展,進而推動對醫療保健 CRM 的需求。這種需求的成長可能與人們日益重視基於價值的護理以及醫療機構改善患者治療結果、降低成本和提高整體護理品質的需求有關。數據驅動的洞察分析在醫療保健 CRM 中至關重要,因為它們允許組織檢查和評估大量患者資料,以確定趨勢、模式和相關性。這使得醫療保健從業者能夠更好地了解患者群體,從而能夠就治療計劃、干預措施和資源分配做出更準確的決策。醫療保健組織還可以透過採用數據驅動的分析來識別高風險患者、預測潛在疾病並主動干預以防止負面結果。同樣,人口健康管理是亞太地區醫療保健 CRM 市場對數據驅動的洞察和分析需求不斷成長的另一個重要驅動力。人口健康管理的重點是改善整個人口的健康結果,要求醫療機構對其患者群體以及影響其健康的因素有廣泛的了解。數據驅動的洞察分析允許醫療保健專業人員根據人口統計、臨床問題和風險因素等標準對患者群體進行細分。這使他們能夠根據不同患者群體的個人需求提供個人化的醫療服務和治療計劃。
此外,醫療保健 CRM 開發人員快速將先進的分析和人口健康管理功能整合到醫療保健 CRM 平台中。這些功能使醫療保健組織能夠使用資料來增強臨床和營運結果,從而提供更好的患者護理並降低成本。因此,對數據驅動的洞察、分析和人口健康管理的需求不斷成長,推動了對醫療保健 CRM 的需求,以改善患者治療結果、降低成本並提高整體護理質量,從而推動亞太醫療保健 CRM 市場的成長。
亞太地區醫療保健 CRM 市場概覽
由於醫療保健產業擴大採用數位技術,預計未來幾年中國醫療保健 CRM 市場將顯著成長。中國政府正在推廣數位醫療解決方案,以提高醫療服務的品質和可近性。根據「健康中國2030」計劃,中國計劃在未來幾年大力投資推動醫療技術創新。這筆支出旨在透過技術進步和醫療保健系統的改善來確保中國的健康公平。
此外,中國是世界上人口最稠密的國家之一。目前人口約14.1億。根據2020年10月發布的全球疾病負擔(GBD)研究,該國人口容易罹患傳染病、慢性病和急性病。中國報告了中風、癌症、阿茲海默症和糖尿病等多種疾病的發生率。患者數量的增加以及對更好的醫療保健服務的需求不斷增加,推動了中國亞太醫療保健 CRM 市場的成長。此外,根據未來健康指數的資料,94%的中國醫療保健專業人員使用數位健康技術或行動健康應用程式。本土主要企業的不斷壯大正在推動中國醫療保健 CRM 市場的成長。製造商正致力於擴大其全球戰略影響力和具有獨特技術能力的專業知識,從而推動中國市場的成長。老齡化人口已成為醫療保健 CRM 軟體需求增加的主要原因之一,因為他們由於身體壓力而無法隨時去醫院,因此需要適當的就診時間表和家庭護理環境的數位預約。 2019年,中國65歲以上人口占總人口的12.6%。人口老化的壓力癌症、阿茲海默症和糖尿病等疾病的盛行率不斷上升。因此,醫院就診和線上預約的需求將持續成長,這對中國的醫療保健 CRM 軟體提出了新的要求。
亞太地區醫療保健 CRM 市場收入及 2030 年預測(百萬美元)
亞太地區醫療保健 CRM 市場細分
亞太地區醫療保健 CRM 市場按部署模式、產品類型、應用程式、最終用戶和國家/地區進行分類。
根據部署模式,亞太地區醫療保健 CRM 市場可分為基於雲端的和本地的。 2022 年,基於雲端的細分市場佔據了更大的市場佔有率。
從產品類型來看,亞太地區醫療保健CRM市場分為營運型CRM、分析型CRM及協作型CRM。 2022 年,營運型 CRM 細分市場將佔據更大的市場佔有率。
按應用分類,亞太地區醫療保健 CRM 市場分為關係管理、個案管理、個案協調、社區外展等。關係管理細分市場在2022年佔據最大的市場佔有率。病例協調部分進一步細分為病患資訊管理和預授權/資格。社區外展部分是進一步的服務外展/推廣和社區健康教育。
按最終用戶分類,亞太地區醫療保健 CRM 市場分為提供者、付款人等。 2022 年,提供商細分市場佔據最大的市場佔有率。
按國家/地區分類,亞太地區醫療保健 CRM 市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2022 年,中國在亞太醫療保健 CRM 市場佔有率中佔據主導地位。
International Business Machines Corp、IQVIA Holdings Inc、Microsoft Corp、Oracle Corp、Pegasystems Inc、Sage Group Plc、Salesforce Inc、SAP SE、SugarCRM Inc、Veeva Systems Inc 和 Zendesk Inc 是亞太地區醫療保健 CRM 領域的領先公司市場。
表中的內容
The Asia Pacific healthcare CRM market was valued at US$ 1,166.17 million in 2022 and is expected to reach US$ 2,745.50 million by 2030; it is estimated to register a CAGR of 11.3% from 2022 to 2030.
Increasing Knowledge About Internet of Things and Artificial Intelligence Boosts Asia Pacific Healthcare CRM Market
The demand for data-driven insights, analytics, and population health management is significantly promoting the development of the healthcare industry, which, in turn, propels the demand for healthcare CRM. This increase in demand can be related to the growing emphasis on value-based care and the demand for healthcare organizations to improve patient outcomes, lower costs, and improve overall care quality. Data-driven insights analytics are critical in healthcare CRM since they allow organizations to examine and evaluate large volumes of patient data to identify trends, patterns, and correlations. This enables healthcare practitioners to understand their patient population better, allowing them to make more accurate decisions about treatment plans, interventions, and resource allocation. Healthcare organizations may also identify high-risk patients, forecast prospective illnesses, and intervene proactively to prevent negative outcomes by employing data-driven analytics. Similarly, population health management is another significant driver of the growing demand for data-driven insights and analytics in the Asia Pacific healthcare CRM market. Population health management, focusing on improving the health outcomes of entire populations, necessitates healthcare organizations having an extensive understanding of their patient population and the factors that impact their health. Data-driven insights analytics allow healthcare professionals to segment their patient population based on criteria including demographics, clinical problems, and risk factors. This allows them to personalize medical services and treatment plans to the individual requirements of distinct patient groups.
Furthermore, healthcare CRM developers rapidly integrate advanced analytics and population health management capabilities into healthcare CRM platforms. These capabilities enable healthcare organizations to use data to enhance clinical and operational outcomes, resulting in better patient care and lower costs. Thus, the increasing demand for data-driven insights, analytics, and population health management propels the demand for healthcare CRM to improve patient outcomes, reduce costs, and enhance the overall quality of care, which fuels the growth of the Asia Pacific healthcare CRM market.
Asia Pacific Healthcare CRM Market Overview
The market for healthcare CRM in China is expected to witness significant growth in the coming years due to the increasing adoption of digital technologies in the healthcare sector. The Chinese government is promoting digital health solutions to improve the quality and accessibility of healthcare services. Under the Healthy China 2030 plan, China plans to invest significantly in advancing its healthcare technology innovation in the coming years. This expenditure is intended to ensure health equity within China through technological advancements and improvements to the healthcare system.
Additionally, China is among the most densely populated countries across the world. The current population is ~1.41 billion. According to the Global Burden of Disease (GBD) study published in October 2020, the population in the country is prone to infectious, chronic, and acute diseases. China reports the incidence of many diseases such as stroke, cancer, Alzheimer's, and diabetes. The rising number of patients and the increasing demand for better healthcare services boost the Asia Pacific healthcare CRM market growth in China. Furthermore, according to data from the Future Health Index, 94% of Chinese healthcare professionals used digital health technology or mobile health apps. The growing presence of local key players is boosting the China healthcare CRM market growth. Manufacturers are focusing on expanding their strategic global presence and specialized expertise with exclusive technological capabilities, leading to the market growth in China. Aging population has become one of the major contributors to the increased demand for healthcare CRM software as they are unable to visit the hospital anytime due to physical stress and thus require a proper schedule for medical visits and a digital appointment for home care settings. In 2019, 12.6% of China's population was over 65. Also, as per WHO, by 2040, ~402 million people (i.e., 28% of the total population) will be over 60. Thus, China is facing pressures of an aging population and constant rise in the prevalence of diseases such as cancer, Alzheimer's disease, and diabetes. As a result, demand for hospital visits and online appointments will continue to rise, setting new requirements for healthcare CRM software in China.
Asia Pacific Healthcare CRM Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Healthcare CRM Market Segmentation
The Asia Pacific healthcare CRM market is categorized into deployment mode, product type, application, and end user, and country.
Based on deployment mode, the Asia Pacific healthcare CRM market is bifurcated cloud based and on-premise. The cloud based segment held a larger market share in 2022.
In terms of product type, the Asia Pacific healthcare CRM market is categorized into operational CRM, analytical CRM, and collaborative CRM. The operational CRM segment held a larger market share in 2022.
By application, the Asia Pacific healthcare CRM market is segmented into relationship management, case management, case coordination, community outreach, and others. The relationship management segment held the largest market share in 2022. The case management segment is further subsegmented into disease management and clinical trials relationship management. The case coordination segment is further subsegmented into patient information management and pre-authorizations / eligibility. The community outreach segment is further services outreach/promotion and community health education.
By end user, the Asia Pacific healthcare CRM market is segmented into providers, payers, and others. The providers segment held the largest market share in 2022.
By country, the Asia Pacific healthcare CRM market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific healthcare CRM market share in 2022.
International Business Machines Corp, IQVIA Holdings Inc, Microsoft Corp, Oracle Corp, Pegasystems Inc, Sage Group Plc, Salesforce Inc, SAP SE, SugarCRM Inc, Veeva Systems Inc, and Zendesk Inc are among the leading companies operating in the Asia Pacific healthcare CRM market.
Table of Content